Dr. Fabio Iwamoto, presenting author at #ASCO24, will give an oral presentation on ST101 in GBM on June 1, 2024. We invite you to attend this scientific session to learn more. More details can be found here: https://lnkd.in/gKV2npZt #ASCO24 #Oncology #Glioblastoma #GBM
Sapience Therapeutics, Inc.’s Post
More Relevant Posts
-
ELCC 2024 wrapped up over the weekend and we’ve compiled the latest post-conference insights, highlighting the top trials as discussed by leading oncologists on X. 🌟 Learn more about LARVOL CLIN and explore our key insights here: https://bit.ly/3TTUFwc. #ELCC2024 #LARVOL #Oncology #Research
To view or add a comment, sign in
-
Join my colleagues from Inizio Medical for a webinar on June 27th where we will dive into the most talked-about topics from #ASCO24, provide in-depth analysis, and highlight key takeaways - this is not to be missed! Learn more and register here: https://lnkd.in/e3pr9aEG #MRX #ResearchPartnership #Oncology #Webinar
To view or add a comment, sign in
-
Check out this head-to head comparison of the humanized NSG-SGM3 model vs Taconic's NOG-Exl model at U Penn! If you are working in oncology research and have been experiencing difficulties due to early myeloid hyperactivation syndrome (MCH) in your in-vivo models, I would love to connect with you and discuss how Taconic can support your studies long-term!
New paper compares the humanized NSG-SGM3 and NOG-EXL showing better outcomes and more translatable results for glioblastoma work. Read more: https://hubs.li/Q02PpxY10 #oncology
To view or add a comment, sign in
-
New paper compares the humanized NSG-SGM3 and NOG-EXL showing better outcomes and more translatable results for glioblastoma work. Read more: https://hubs.li/Q02PpxY10 #oncology
To view or add a comment, sign in
-
👉 Watch this video made by FLASH Radiotherapy & Particle Therapy - FRPT to discover how to work on an abstract and get some tips. #FRPT2024 #Oncology #FLASHrt
💻 Are you currently working on an abstract and in need of some tips? 🎙️ Lorea Iturri shares her top tips to increase the chances of your work being selected. ➡️ https://bit.ly/3rUwoqy #FRPT2024 #Oncology #FLASHrt
FRPT 2024: Lorea Iturri
To view or add a comment, sign in
-
#WhatThisMeans: A Major Inflection Point - The Moleculin Opportunity in 2024 and Beyond Series (Part 3 of 3). CEO, Wally Klemp, summarizes recent progress and highlights the potential value of Annamycin. https://lnkd.in/ersYUSGd #Oncology #VirtualInvestor
To view or add a comment, sign in
-
Thought it would be interesting to take the ADC trial data from Beacon and visualise it over time. If this is well received I might do something similar on how ADC targets and payloads have changed over the years. In the meantime, we're running an ADC webinar later today, which you can register for here: https://ter.li/rzae33 #ADCs #Oncology
To view or add a comment, sign in
-
Working towards a better understanding of immuno-oncology? Listen to this chat of a panel of scientists who are researching towards understanding CAR-T therapy patient factors. Watch on-demand now: https://ow.ly/NqOq50QtoNt #flowcytometry #oncology #EmoryMedicine #immunooncology
To view or add a comment, sign in
-
Really looking forward to this, off the back of the recent Nature Medicine article - come join us to learn more about the DigiONE pilot, federated analytics to get patient level data equivalent insights and what is ahead
How did the DigiONE technology pilot develop an insight network to transform the speed and richness of European #oncology Real-World Evidence? How were digital pragmatic trial opportunities enhanced? Join us on March 12: https://lnkd.in/gfpw_pwj #precisionmedicine #datanetwork
To view or add a comment, sign in
-
Highlighting more insights from AACR 2024! 💫 LARVOL CLIN has been compiling the latest post-conference insights, highlighting the top trials as discussed by 2500+ leading oncologists on X. Explore more analytics here: https://bit.ly/3vWSleR #AACR2024 #LARVOL #CancerResearch #Oncology
To view or add a comment, sign in
3,220 followers